MercyOne Genesis Silvis Cancer Center — Silvis, Illinois

MercyOne Genesis Silvis Cancer Center is a clinical research site located in Silvis, Illinois, United States 61282.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

MercyOne Genesis Silvis Cancer Center has participated in 16 clinical trials with 15 currently active.

Therapeutic areas: Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7.

Sponsors: National Cancer Institute (NCI), NRG Oncology, Alliance for Clinical Trials in Oncology.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MercyOne Genesis Silvis Cancer Center?

MercyOne Genesis Silvis Cancer Center has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MercyOne Genesis Silvis Cancer Center conducted?

MercyOne Genesis Silvis Cancer Center has 16 clinical trials on record, with 15 currently active. Their work covers Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7.

Is MercyOne Genesis Silvis Cancer Center accredited by Crixeo Health?

Yes — MercyOne Genesis Silvis Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about MercyOne Genesis Silvis Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.